These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3671489)

  • 1. Early physiological effects of lithium treatment: electrooculographic and adaptometric findings in patients with affective and schizoaffective psychoses.
    Kaschka WP; Mokrusch T; Korth M
    Pharmacopsychiatry; 1987 Sep; 20(5):203-7. PubMed ID: 3671489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrooculography and dark adaptation in patients with affective and schizoaffective psychoses: early physiological effects of carbamazepine and lithium.
    Kaschka WP; Thürauf N; Mokrusch T; Korth M
    Pharmacopsychiatry; 1988 Nov; 21(6):404-6. PubMed ID: 3244776
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduced dark-adaptation: an indication of lithium's neuronal action in humans.
    Emrich HM; Zihl J; Raptis C; Wendl A
    Am J Psychiatry; 1990 May; 147(5):629-31. PubMed ID: 2327491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow-release lithium in treatment of schizoaffective syndromes.
    Romeo R; Bastianello S; Janiri L; Mauro P; Pirrongelli C
    Int J Clin Pharmacol Res; 1985; 5(3):205-11. PubMed ID: 4018956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Individual prognosis in endogenous affective and schizoaffective psychoses: clinical predictors].
    Evsegneev RA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(1):78-81. PubMed ID: 1319658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up.
    Baethge C; Gruschka P; Berghöfer A; Bauer M; Müller-Oerlinghausen B; Bschor T; Smolka MN
    J Affect Disord; 2004 Apr; 79(1-3):43-50. PubMed ID: 15023479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissimilar effects of lithium and carbamazepine on erythrocyte lithium transport in vivo: clinical implications.
    Rybakowski J; Lehmann W; Matkowski K
    Pol J Pharmacol Pharm; 1990; 42(2):113-20. PubMed ID: 2274469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of lithium treatment on cation transport processes in erythrocytes of patients with affective illnesses.
    Rybakowski J; Potok E; Strzyzewski W; Chłopocka-Woźniak M
    Pol J Pharmacol Pharm; 1983; 35(3):209-15. PubMed ID: 6622301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of lithium treatment and brain lithium concentration in patients with unipolar and schizoaffective disorder--a study with magnetic resonance spectroscopy.
    Riedl U; Barocka A; Kolem H; Demling J; Kaschka WP; Schelp R; Stemmler M; Ebert D
    Biol Psychiatry; 1997 Apr; 41(8):844-50. PubMed ID: 9099410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An attempt to assess the action of lithium on the neutrophil leukocyte system in patients with affective psychoses].
    Wysocki H; Rybakowski J; Wierusz-Wysocka B; Kapelski Z; Szajnerman Z
    Psychiatr Pol; 1980; 14(4):362-7. PubMed ID: 7443884
    [No Abstract]   [Full Text] [Related]  

  • 11. Contralateral eye movements and alpha reactivity of lithium patients in recognition tasks.
    Opgenoorth E; Wolf R; Presslich O; Anderer P
    Pharmacopsychiatry; 1987 Sep; 20(5):208-12. PubMed ID: 3671490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte lithium transport during lithium treatment in patients with affective disorders.
    Zaremba D; Rybakowski J
    Pharmacopsychiatry; 1986 Mar; 19(2):63-7. PubMed ID: 3085111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Affective, schizoaffective and schizophrenic psychoses. A comparative long-term study].
    Marneros A; Deister A; Rohde A
    Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1991; 65():1-454. PubMed ID: 1791861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine in treatment-refractory mood disorders.
    Kimmel SE; Calabrese JR; Woyshville MJ; Meltzer HY
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():91-3. PubMed ID: 7961583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of nifedipine for overcoming the insufficient preventive effect of lithium carbonate in patients with affective and schizoaffective psychoses].
    Snedkova LV; Vasiuk VK; Fursov GG; Panteleeva GP
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(10):35-9. PubMed ID: 9424345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium and mood change in affective disorder patients.
    Insel TR; van Kammen DP; Cohen RM; Alterman IS; Murphy DL
    Biol Psychiatry; 1981 Nov; 16(11):1051-7. PubMed ID: 7349619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Unsolved problems in the indications for lithium prophylaxis in affective and schizoaffective disorders].
    Angst J
    Bibl Psychiatr; 1981; (161):32-44. PubMed ID: 7271758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Schizoaffective psychosis and the lithium therapy of patients suffering from schizoaffective schizophrenia].
    Baastrup PC
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(9):1406-8. PubMed ID: 1179906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients.
    Placidi GF; Lenzi A; Lazzerini F; Cassano GB; Akiskal HS
    J Clin Psychiatry; 1986 Oct; 47(10):490-4. PubMed ID: 3093468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative evaluation of clinical and economic effectiveness of preventive therapy of affective and schizoaffective psychoses].
    Ushakov IuV; Kostiukova EG; Kalugina LI; Mirzoian MG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(9):79-82. PubMed ID: 2176049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.